In May, the company announced the failure of the monoclonal antibody birtamimab to improve mortality in a phase 3 trial of ...

In this exclusive MedPage Today video, investigator Shahzad Raza, MD, of the Cleveland Clinic Cancer Institute, explains why ...

AL amyloidosis is associated with a clonal plasma cell dyscrasia and is caused by abnormal or excessive production of amyloidogenic immunoglobulin light chains, which aggregate into oligomers and ...

Amyloidosis is a group of conditions that cause an abnormal protein called amyloid to build up in the body. Treatment depends on the type of amyloidosis but may include medications and organ ...

Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Novo Nordisk has recently completed a clinical study titled ...

Multiple myeloma and amyloidosis begin the same way – in plasma cells, white blood cells that help your immune system. But multiple myeloma (MM) is a rare blood cancer while amyloidosis is a ...

Amyloidosis occurs due to a buildup of amyloid proteins in the body. Along with treatment, complementary therapy can help with symptoms. Some examples include movements, such as yoga, sleep ...

Cardiac amyloidosis portends a poor prognosis, with a median survival less than 6 months without treatment. However, if it is recognized early, there are specific treatments available.

Amyloidosis occurs when the proteins in the body become sticky and begin to clump together, Sperry says. In the brain, there's a type of amyloidosis that people know as Alzheimer’s disease.

Wainua is an injectable medicine. Here’s how it treats hereditary transthyretin-mediated amyloidosis (hATTR).

Cardiac amyloidosis portends a poor prognosis, with a median survival less than 6 months without treatment. However, if it is recognized early, there are specific treatments available.